Bright Minds Biosciences DRUG
NASDAQ DRUG
$49.82 +0.08 (+0.16%)
At close: Sep 30, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Total Current Liabilities (2019 - 2026)

Updated

Bright Minds Biosciences' Total Current Liabilities was $1.84 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 321.2% from $436,630 a year earlier but down 34.2% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Total Current Liabilities at Bright Minds Biosciences came in at $1.67 million, up 329.9% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of 71.6% (FY2020 to FY2025).
  • In earlier fiscal years, Total Current Liabilities was $388,689 in FY2024 (+86.6%), $208,308 in FY2023 (-81.9%), $1.15 million in FY2022 (+128.3%) and $505,261 in FY2021 (+350.0%).
  • Quarterly Total Current Liabilities has moved between $130,602 (fiscal Q3 2024) and $2.79 million (fiscal Q2 2026) over five years.
  • Compared with a year earlier, Total Current Liabilities has increased for five straight quarters, with growth averaging 209.2% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was fiscal Q2 2026 (growth of 528.6%); the worst was fiscal Q4 2023 (a decline of 81.4%).
  • Per Business Quant data, DRUG's Total Current Liabilities in the three fiscal quarters before Q3 2026 was $2.79 million (Q2 2026), $1.13 million (Q1 2026) and $1.7 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 54.90 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 41.64 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -31.55 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.94 Bn
10 Bright Minds Biosciences 379.80 Mn 379.80 Mn - 1.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.84 Mn
Mar 31, 2026 2.79 Mn
Dec 31, 2025 1.13 Mn
Sep 30, 2025 1.70 Mn
Jun 30, 2025 436,629.57
Mar 31, 2025 444,609.02
Dec 31, 2024 330,380.13
Sep 30, 2024 387,552.88
Jun 30, 2024 130,602.17
Mar 31, 2024 627,669.70
Dec 31, 2023 627,410.87
Sep 30, 2023 209,499.05
Jun 30, 2023 536,598.36
Mar 31, 2023 743,977.73
Dec 31, 2022 389,049.88
Sep 30, 2022 1.13 Mn
Jun 30, 2022 302,225.28
Mar 31, 2022 792,250.41
Dec 31, 2021 388,414.17
Sep 30, 2021 507,288.34
API Access

Bright Minds Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=DRUG&period=max&api_key=YOUR_API_KEY